Prostate Cancer
Variability in prostate cancer detection among radiologists and urologists using MRI fusion biopsy.
February 20, 2024
Evaluation of Proclarix in the diagnostic work-up of prostate cancer.
February 20, 2024
Low PSA radiographic disease progression on C11-choline PET.
February 20, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.
February 20, 2024
Quantitative calibration of Tb-161 SPECT/CT in view of personalised dosimetry assessment studies.
February 20, 2024
Prostate Cancer Screening Uptake in Transgender Women.
February 19, 2024
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
February 19, 2024
A phase 1 study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer.
February 16, 2024
eHealth literacy in prostate cancer: A systematic review.
February 16, 2024
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
February 16, 2024
Novel hormonal therapy versus standard of care-A registry-based comparative effectiveness evaluation for mCRPC-patients.
February 16, 2024
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.
February 16, 2024
Initial COBRA Results: Clarity’s SAR-bisPSMA Is Safe and Highly Effective in Detecting Tumours in Prostate Cancer Patients. Phase 3 Planning Underway.
February 15, 2024